EMA Rejects Bevacizumab Drug For Use In Wet AMD

European Commission Approves COVID-19 Products Ronapreve & Regkirona

Nearly a year and a half after it was filed for approval, the EU regulator has rejected a mystery injectable product containing the monoclonal antibody bevacizumab for ophthalmic use.

Macular degeneration - loss of the central field of vision.
Macular degeneration can seriously impair vision • Source: Alamy

The European Medicines Agency has recommended against EU marketing approval for Ipique (bevacizumab), which would have been the first drug containing the antibody to be authorized for use in neovascular (wet) age-related macular degeneration (AMD).

The EMA today announced that its human drugs committee, the CHMP, issued a negative opinion on the product on 11...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Europe

  • EU Biosimilar Filings, Opinions And Approvals

     
    • By 

    <p>Executive Summary</p> <p>A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.</p>

  • EU Pharma Reform: What You Need to Know Now

     

    As the reform of the EU pharmaceutical legislation progresses through the legislative process, the Pinks Sheet offers an infographic highlighting some of the key changes being proposed that will reshape the way drug companies run their business.

  • New EU Approvals

    <p>Executive Summary<p> <p>The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, incl/ding Ixchiq, Valneva's chikungunya virus vaccine</p>

More from Geography